InMode Ltd. Ordinary Shares (INMD) — Analysis Summary
InMode Ltd. Ordinary Shares (INMD) has a market cap of $853.96M with year-over-year revenue growth of -6.2%. Net margin stands at 25.3%. The stock trades at a P/E ratio of 9.1.
Key Takeaways
- Revenue changed -6.2% year-over-year
- Net margin of 25.3%
- P/E ratio of 9.1
Compared with its sector, INMD posted revenue growth of -6.2% and trades at a P/E of 9.1.
InMode Ltd. Ordinary Shares (INMD)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Employees
660
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.